These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17425972)

  • 41. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis.
    Hamelers IH; Staffhorst RW; Voortman J; de Kruijff B; Reedijk J; van Bergen en Henegouwen PM; de Kroon AI
    Clin Cancer Res; 2009 Feb; 15(4):1259-68. PubMed ID: 19228729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The antitumor effect of liposome-encapsulated cisplatin on rat osteosarcoma and its enhancement by caffeine.
    Karita M; Tsuchiya H; Kawahara M; Kasaoka S; Tomita K
    Anticancer Res; 2008; 28(3A):1449-57. PubMed ID: 18630498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of cisplatin on the expression of Pokemon gene: experiment with different human lung cancer cells].
    Zhao ZH; Wang SF; Yu L; Wang J; Cong DG; Chang H; Wang XF; Zhang TW; Zhang J; Fu K; Jiang JY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1211-3. PubMed ID: 18844119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of Smac in cisplatin-induced apoptosis of non-small cell lung cancer cells].
    Cheng XD; Cai SX; Zhao HJ; Li WJ; Tong WC
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):389-91. PubMed ID: 18359697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells.
    Zhang LJ; Hao YZ; Hu CS; Ye Y; Xie QP; Thorne RF; Hersey P; Zhang XD
    Anticancer Drugs; 2008 Feb; 19(2):159-66. PubMed ID: 18176112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
    Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
    Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
    Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
    J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
    Deng G; Yu JH; Ye ZQ; Hu ZQ
    Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New cytotoxic steroids from the soft coral Clavularia viridis.
    Duh CY; Lo IW; Wang SK; Dai CF
    Steroids; 2007 Jun; 72(6-7):573-9. PubMed ID: 17485104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system.
    Min Y; Mao CQ; Chen S; Ma G; Wang J; Liu Y
    Angew Chem Int Ed Engl; 2012 Jul; 51(27):6742-7. PubMed ID: 22639083
    [No Abstract]   [Full Text] [Related]  

  • 52. Cisplatin nanocapsules.
    de Kroon AI; Staffhorst RW; Kruijff Bd; Burger KN
    Methods Enzymol; 2005; 391():118-25. PubMed ID: 15721377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependency.
    Martelli L; Ragazzi E; Di Mario F; Basato M; Martelli M
    Anticancer Res; 2009 Oct; 29(10):3931-7. PubMed ID: 19846931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of a New Hydroxyapatite Nanoparticle as a Drug Delivery System to Oral Squamous Cell Carcinoma Cells.
    Murata T; Kutsuna T; Kurohara K; Shimizu K; Tomeoku A; Arai N
    Anticancer Res; 2018 Dec; 38(12):6715-6720. PubMed ID: 30504381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase-contrast microscopy studies of early cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis.
    Janson V; Behnam-Motlagh P; Henriksson R; Hörstedt P; Engström KG; Grankvist K
    Exp Lung Res; 2008 Feb; 34(2):49-67. PubMed ID: 18266129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Defining targets of modulation of human tumor cell response to cisplatin.
    Beretta GL; Gatti L; Corna E; Carenini N; Zunino F; Perego P
    J Inorg Biochem; 2008 Jul; 102(7):1406-15. PubMed ID: 18279962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utilization of a right-handed coiled-coil protein from archaebacterium Staphylothermus marinus as a carrier for cisplatin.
    Eriksson M; Hassan S; Larsson R; Linder S; Ramqvist T; Lövborg H; Vikinge T; Figgemeier E; Müller J; Stetefeld J; Dalianis T; Ozbek S
    Anticancer Res; 2009 Jan; 29(1):11-8. PubMed ID: 19331128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.
    Ezawa S; Suzuki N; Ohie S; Higashiguchi A; Hosoi F; Kitazato K; Susumu N; Aoki D
    Gynecol Oncol; 2008 Mar; 108(3):627-31. PubMed ID: 18048092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.
    Woods DC; Alvarez C; Johnson AL
    Gynecol Oncol; 2008 Mar; 108(3):632-40. PubMed ID: 18191995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
    Wu XX; Kakehi Y
    Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.